Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15088-8 Parathyrin.C-terminal SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Parathyrin.C-terminal [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15088-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PTH-C SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Parathormone; Parathyrin carboxy-terminal; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-C; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
15089-6 Phospholipid SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Phospholipid [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15089-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Phospholipid SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Lipid; Phoslpd; Phospholipids; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
1509-9 Glucose^1H post 75 g glucose PO MCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1509-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose 1h p 75 g Glc PO Ur-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 hour; 1.0Hr; 1h p 75 g Glc PO; 60 min; 60 minutes; 60M; 60min; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
15090-4 Porphyrins SRat Stool 24H Qn &nbsp; &nbsp; ACTIVE Porphyrins [Moles/time] in 24 hour Stool &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15090-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Porphyrins 24h Stl-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
15091-2 Pregnanediol SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Pregnanediol [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15091-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Pregnanediol Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Point in time; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15092-0 Pregnanetriol SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Pregnanetriol [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15092-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Pregntrl Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Point in time; Pregnanetr; Pregntrl; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.58 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15093-8 Protoporphyrin.free SCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Protoporphyrin Free [Moles/volume] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15093-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FEP Bld-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Blood; Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; FEP; FR; Free erythrocyte protoporphyrin; Hematology; Heme; Level; Non-protein bound; Point in time; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
15094-6 Testosterone SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Testosterone [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15094-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Testost Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15095-3 Testosterone SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Testosterone [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15095-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Testost 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Testo; Testos; Testost; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
15096-1 Uroporphyrin SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Uroporphyrin [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15096-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Uropor 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Urophorph 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(24.h) &nbsp; &nbsp; &nbsp; 0
15097-9 Vanillylmandelate SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Vanillylmandelate [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15097-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 VMA Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; Level; MHMA; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15098-7 Amikacin^random SCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Amikacin [Moles/volume] in Serum or Plasma --random &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15098-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Amikacin Rand SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Amikin; Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15099-5 Amiodarone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Amiodarone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15099-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Amiodarone SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Cordarone; DRUG/TOXICOLOGY; Drugs; Level; Pacerone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
151-1 Cephalexin Titr Isolate+Ser Pt SemiQn SBT &nbsp; ACTIVE Cephalexin [Susceptibility] by Serum bactericidal titer &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 151-1 &nbsp; SBT &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephalexin Titr SBT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Cefadine; Dilution factor; Dilution Factor (Titer); GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; Palitrex; Point in time; Random; Salitex; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
1510-7 Glucose^1H post dose insulin IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1510-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose 1h p Ins IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
15100-1 Barbiturates SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Barbiturates [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15100-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Barbiturates SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15101-9 Chloramphenicol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Chloramphenicol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15101-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Chloramphen SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Amphicol; Biophenicol; c225; Chloramphen; Chloromycetin; DRUG/TOXICOLOGY; Drugs; Level; Mychel; Paraxin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15102-7 Codeine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Codeine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15102-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Codeine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Addiction; c260; C300; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Methylmorphine; Morphine methyl ether; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15103-5 cycloSPORINE SCnc Ser Pt Qn &nbsp; &nbsp; DISCOURAGED cycloSPORINE [Moles/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15103-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 cycloSPORINE Ser-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Level; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; Serum; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15104-3 Digitoxin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Digitoxin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15104-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Digitoxin SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Crystidigin; Crystodigin; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Purodigin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15105-0 Flecainide SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Flecainide [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15105-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Flecainide SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tambocor 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15106-8 Gentamicin^random SCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Gentamicin [Moles/volume] in Serum or Plasma --random &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15106-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Gentamicin Rand SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Aminoglycosides; c213; DRUG/TOXICOLOGY; Drugs; Garamycin; Genirr; Genj; Gent; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15107-6 Imipramine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Imipramine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15107-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Imipramine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Imipra; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tofranil 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
15108-4 Methadone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Methadone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15108-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Methadone SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; METD; Methadose; MTD; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
15109-2 Midazolam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Midazolam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 15109-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Midazolam SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Versed 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
108,248 results found